发明名称 |
Aptamer-mediated drug release |
摘要 |
Disclosed are aptamer/drug conjugate complexes and the use of such complexes, together with a trigger compound, to inducibly release a drug. Also disclosed are methods for establishing a drug reservoir in a subject using these complexes, whereby drug may be released as needed. One example of such a complex is an aptamer/insulin conjugate complex from which insulin may be released by an innocuous, orally administrable trigger, such as quinine. |
申请公布号 |
US9243024(B2) |
申请公布日期 |
2016.01.26 |
申请号 |
US201113245201 |
申请日期 |
2011.09.26 |
申请人 |
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
发明人 |
Stojanovic Milan N.;Pei Renjun;Taylor Steven Michael Forna |
分类号 |
C07H21/02;A61K31/70;A61K31/44;A61K31/7088;A01K67/00 |
主分类号 |
C07H21/02 |
代理机构 |
Baker Botts L.L.P. |
代理人 |
Baker Botts L.L.P. |
主权项 |
1. An aptamer complex comprising:
(i) a first trigger-binding oligonucleotide portion comprising the sequence of SEQ ID NO:12; and (ii) a drug conjugate comprising a second releasable oligonucleotide portion comprising the sequence of SEQ ID NO: 2 or SEQ ID NO: 13 linked to a drug selected from the group consisting of a pharmaceutical compound, a peptide, a protein, a peptidomimetic compound, and an imaging agent; wherein the binding of a trigger compound releases the drug conjugate from the complex, and wherein the trigger compound is selected from the group consisting of quinine and quinidine. |
地址 |
New York NY US |